September 11, 2020
About the author: Dr. Liz Kwo is currently the staff VP of clinical data analytics at Anthem, and previously cofounded and served as CEO of telemedicine second opinion company InfiniteMD. She received an MD from Harvard Medical, an MBA from Harvard Business School and an MPH from the Harvard T.H. Chan School of Public Health.
COVID-19 has reshaped the way humans interact with technology in...
August 13, 2020
Research by UK-based digital firm Babylon found that artificial intelligence (AI) using the principles of causal reasoning scored higher than 70% of GPs in diagnosing written test cases.
Up until now, the firm’s AI symptom checkers have provided advice using an algorithm which relies on correlations with patient symptoms and medical history.
But a peer-reviewed study, published in Nature...
August 12, 2020
A new investigation of roughly two million Medicare beneficiary claims suggests that machine learning (ML) could be used to predict which patients are at greatest risk of severe respiratory infections, and to place them in more appropriate care facilities in their area.
The study was published online in the American Journal of Managed Care and funded by the HEALTH[at]SCALE Corporation, a...
August 5, 2020
Sight Diagnostics, an Israeli startup developing a machine-vision-based finger-prick analysis device, announced today $71 million in Series D funding. Koch Disruptive Technologies, Longliv Ventures and OurCrowd all participated in the round.
According to the company, this newest raise brings its lifetime funding to more than $124 million.
WHAT IT DOES
Founded in 2011, Sight Diagnostics offers an...
June 30, 2020
This morning Owkin, a medical research company that uses machine learning, announced that its Series A funding round has reached $70 million. This comes after Mubadala Capital and Bpifrance entered with a late $18 million in investment.
The Series A has been in the works for some time. The money has trickled in periodically. In May it announced a $25 million dollar raise. But the Series A round...
May 14, 2020
Artificial intelligence is knocking on the healthcare industry's doors. From computation-driven R&D for new drugs, to objective image analysis, to mass-scale disease screening and diagnosis, more and more instances of the technology are pitching solutions to some of the industry's most pressing challenges.
Regulators once stood as the primary hurdle for AI and associated technologies like...
January 7, 2020
Editor's note: This story has been updated with additional statements from Pear Therapeutics.
Pear Therapeutics pulled back the curtain this morning on a number of new deals between the prescription digital therapeutics maker and other tech companies or researchers.
Ranging from virtual reality therapies to voice biomarker tech, the moves appear to be an effort from Pear to add new products to...
December 19, 2019
ECG algorithm picks up Breakthrough Device status. Eko, the maker of tools for monitoring heart function, announced yesterday that a novel ECG-based algorithm for detecting lowered left ventricular ejection fraction has received Breakthrough Device designation from the FDA. By analyzing a 15-second clip of ECG data collected via the company’s other products, the algorithm aims to assist with...
December 18, 2019
OM1, a Boston-based artificial intelligence platform for clinical real-world evidence, has raised $50 million in Series C funding. Scale Venture Partners led the round consisting of support from prior backers General Catalyst, Polaris Partners and 7wire Ventures.
WHAT THEY DO
OM1’s cloud platform employs AI machine learning organize and analyze large datasets for real-world measures of clinical...
November 29, 2019
As pressures on healthcare systems intensify, an increasing number of consumers are turning to the use of symptom checkers in the search for fast answers – or guidance – to any concerns that they may have. But although these tools have become popular, questions around their accuracy, and not only, are plaguing the digital health space.
Last week, at Slush, Ada Health cofounder and chief medical...